We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
Cap. Flow
-$1.78B
Cap. Flow %
-1.61%
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46M
2
PLTR icon
Palantir
PLTR
+$40.3M
3
SW
Smurfit Westrock
SW
+$39.2M
4
DELL icon
Dell
DELL
+$29.2M
5
AVTR icon
Avantor
AVTR
+$27.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$97.8M
2
LLY icon
Eli Lilly
LLY
+$58.2M
3
NVDA icon
NVIDIA
NVDA
+$48.6M
4
XOM icon
ExxonMobil
XOM
+$31.3M
5
BAC icon
Bank of America
BAC
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 30.19%
2 Financials 12.91%
3 Healthcare 11.38%
4 Consumer Discretionary 10.81%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RM icon
2701
Regional Management Corp
RM
$303M
$406K ﹤0.01%
12,410
-20
-0.2% -$619
NGVC icon
2702
Vitamin Cottage Natural Grocers
NGVC
$654M
$406K ﹤0.01%
13,671
-1,003
-7% -$25.5K
CRMT icon
2703
America's Car Mart
CRMT
$26.9M
$405K ﹤0.01%
9,671
-335
-3% -$19.4K
VYGR icon
2704
Voyager Therapeutics
VYGR
$201M
$404K ﹤0.01%
69,143
-3,318
-5% -$24.1K
BWMN icon
2705
Bowman Consulting
BWMN
$477M
$402K ﹤0.01%
16,707
+877
+6% +$24.3K
INZY
2706
DELISTED
Inozyme Pharma
INZY
$402K ﹤0.01%
76,817
-187
-0.2% -$971
IRBT
2707
DELISTED
iRobot
IRBT
$401K ﹤0.01%
46,188
-2,852
-6% -$24.7K
ESPR
2708
DELISTED
Esperion Therapeutics
ESPR
$401K ﹤0.01%
243,090
-8,948
-4% -$18.1K
CMCL icon
2709
Caledonia Mining Corp
CMCL
$420M
$401K ﹤0.01%
26,805
+6,178
+30% +$74.8K
NHY
2710
DELISTED
NORSK HYDRO A. S. ADR
NHY
$401K ﹤0.01%
62,436
+4,160
+7% +$26.7K
CERS icon
2711
Cerus
CERS
$474M
$401K ﹤0.01%
230,337
-22,107
-9% -$46.4K
TIMB icon
2712
TIM SA
TIMB
$8.8B
$401K ﹤0.01%
23,266
+1,600
+7% +$25.4K
KRO icon
2713
KRONOS Worldwide
KRO
$989M
$400K ﹤0.01%
32,148
-669
-2% -$7.74K
FNLC icon
2714
First Bancorp
FNLC
$399M
$399K ﹤0.01%
15,172
-857
-5% -$22.4K
ZVRA icon
2715
Zevra Therapeutics
ZVRA
$686M
$399K ﹤0.01%
57,480
+606
+1% +$4.11K
TBI
2716
Trueblue
TBI
$311M
$399K ﹤0.01%
50,537
-1,451
-3% -$13.1K
BIDU icon
2717
Baidu
BIDU
$37.2B
$399K ﹤0.01%
3,785
SFST icon
2718
Southern First Bancshares
SFST
$600M
$398K ﹤0.01%
11,693
-186
-2% -$5.99K
WSBF icon
2719
Waterstone Financial
WSBF
$375M
$397K ﹤0.01%
26,997
-1,590
-6% -$23K
XPOF icon
2720
Xponential Fitness
XPOF
$211M
$396K ﹤0.01%
31,972
-378
-1% -$5.55K
SRTA
2721
Strata Critical Medical Inc
SRTA
$512M
$393K ﹤0.01%
133,742
+47,210
+55% +$150K
PKOH icon
2722
Park-Ohio Holdings
PKOH
$761M
$393K ﹤0.01%
12,802
+512
+4% +$14.5K
MEC icon
2723
Mayville Engineering Co
MEC
$617M
$391K ﹤0.01%
18,572
-709
-4% -$13.3K
BOOM icon
2724
DMC Global
BOOM
$157M
$391K ﹤0.01%
30,126
-1,862
-6% -$23.6K
CIO
2725
DELISTED
City Office REIT
CIO
$391K ﹤0.01%
66,887
-2,088
-3% -$11.8K

Similar funds

RhumbLine Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
  • RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
  • RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
  • RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
  • RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
  • RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
  • RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.